Yi-li Cai

Identification and validation of a lipid metabolism gene signature for predicting biochemical recurrence of prostate cancer after radical prostatectomy

Z. Zhao, Yu-xiang Ma, Yangzhou Liu, 2022, Frontiers in Oncology.

Novel biomarkers predict prognosis and drug-induced neuroendocrine differentiation in patients with prostate cancer

Z. Zhao, Yu-xiang Ma, Yangzhou Liu, 2023, Frontiers in Endocrinology.

Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma.

W. Guo, Han-guang Zhu, Jian Sun, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A New Signature That Predicts Progression-Free Survival of Clear Cell Renal Cell Carcinoma with Anti-PD-1 Therapy

Z. Zhao, Yu-xiang Ma, Yangzhou Liu, 2023, International journal of molecular sciences.

Long-term results of a randomized phase III trial of TPF induction chemotherapy followed by surgery and radiation in locally advanced oral squamous cell carcinoma

Jian Sun, W. Guo, Han-guang Zhu, 2015, Oncotarget.